In situation, when RCCs with SMARCB1 loss is encountered, and sickle trait or other hemoglobinopathies are absent, it is currently recommended to classify them as RCC unclassified with medullary phenotype. The gene discussed is SMARCB1; the disease is renal cell carcinoma.